CLOSING THE CLINICAL GAP

MyBiotics is developing live biotherapeutics drugs based on the company’s unique discovery, delivery and colonization technologies.

INNOVATIVE TECHNOLOGIES

Superior clinical effect and proven bacteria colonization using MyCrobe and SuperDonor technology

THERAPEUTICAL PROGRAMS

MBX-SD-201 for CDI and MBX-MC-101 for acute dysbiosis bring MyBiotics breakthrough technologies to the product development stage

previous arrow
next arrow
Slider

ABOUT

MyBiotics is a life science company developing probiotic and live bacteria based products to improve health and life quality. The company developed MyCrobe a proprietary innovative live bacteria delivery system while our products combines this technology with a set of unique bacteria strains targeted to solve specific health problems in wide range of aspects …

VISION

Our vision is to improve medical treatment and make a significant positive impact on the lives of millions. We intend to achieve this goal using a long list of targeted probiotic products. We wish to make this vision a reality by providing a unique and targeted probiotic products for a long list of health problems and imbalances using the most advanced and natural technology available in the market …

PRODUCTS & TECHNOLOGY

MyCrobe products relay on Mybiotics unique and advanced live bacteria delivery system combined with a set of specific and targeted bacteria strains relevant for specific use. MyCrobe products uses nature’s ancient method of bacteria introduction and colonization to the human body, it combines this method with the bacteria’s most efficient survival tools …